Order Article Reprints

Nesline MK, Previs RA, Dy GK, Deng L, Lee YH, DePietro P, Zhang S, Meyers N, Severson E, Ramkissoon S, et al. PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes. Cancers. 2023; 15(19):4789. https://doi.org/10.3390/cancers15194789

Nesline, Mary K., Rebecca A. Previs, Grace K. Dy, Lei Deng, Yong Hee Lee, Paul DePietro, Shengle Zhang, Nathan Meyers, Eric Severson, Shakti Ramkissoon, and et al. 2023. "PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes" Cancers 15, no. 19: 4789. https://doi.org/10.3390/cancers15194789

Nesline, M. K., Previs, R. A., Dy, G. K., Deng, L., Lee, Y. H., DePietro, P., Zhang, S., Meyers, N., Severson, E., Ramkissoon, S., Pabla, S., & Conroy, J. M. (2023). PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes. Cancers, 15(19), 4789. https://doi.org/10.3390/cancers15194789